作者
L Braghieri, GM Mondellini, A Javaid, A.K. Kim, J.A. Fried, A. Masoumi, V.K. Topkara, K.L. Antler, G.T. Sayer, N. Uriel, H. Takayama, Y. Naka, K.T. Takeda, P.C. Colombo, M Yuzefpolskaya
发表日期
2020/4/1
期刊
The Journal of Heart and Lung Transplantation
卷号
39
期号
4
页码范围
S25
出版商
Elsevier
简介
Purpose
Right ventricular failure (RVF) after LVAD is associated with increased morbidity and mortality. "Delayed right ventricular assist device (RVAD)", as a surgical or percutaneous rescue strategy, carries high complication rates. We recently changed our practice and use "Upfront RVAD" (concurrent with LVAD implant) in selected high-risk pts (INTERMACS 1, severe RVF and renal failure). We sought to investigate the effect of this novel strategy on in-hospital mortality and adverse events.
Methods
We retrospectively reviewed consecutive pts who received primary LVAD implant between 1/2015 and 8/2019. This cohort was divided into 4 groups (Gs): G1- no evidence of RVF and no RVAD; G2 - RVF treated with inotropes >2 wks; G3 - Delayed RVAD; G4 - Upfront RVAD. Clinical outcomes included in-hospital mortality, renal replacement therapy (RRT), stroke and length of stay (LOS).
Results
225 pts were enrolled …
学术搜索中的文章
L Braghieri, GM Mondellini, A Javaid, A Kim, JA Fried… - The Journal of Heart and Lung Transplantation, 2020